INTRODUCING PROVASCTEC – A cell therapy for patients suffering from chronic limb ischemia

ProVascTec, an NLC venture, will help patients with critical limb ischemia by triggering new vascular tissue growth through novel cell therapy.  Atherosclerosis describes the build-up of fats, cholesterol, and other substances within the artery wall. This build-up, also called plaque, can cause arteries to narrow and eventually completely block the arterial blood flow. If the […]